AI Insights · Timothy · October 2022
Top 5 High Fantasy Games on iOS in Latin America: Q3 2022
Discover the performance trends of the top 5 high fantasy games on iOS in Latin America during Q3 2022, including downloads, revenue, and active users.
In the third quarter of 2022, high fantasy games on iOS in Latin America showcased notable performance trends. Here, we delve into the analytics of the top 5 games: Clash Royale, Evony, Clash of Clans, Akinator, and Genshin Impact. Data is sourced from Sensor Tower, offering deeper insights into the gaming landscape.
Clash Royale from Supercell experienced fluctuations in weekly revenue, peaking at $189K in the first week of August. Weekly downloads saw a moderate decline, starting at 51K in late June and dropping to approximately 38K by the end of September. Active users also showed a decreasing trend, from 2.25M to 1.89M over the quarter.
Evony by TOP GAMES INC. displayed consistent revenue growth, reaching a high of $61K in mid-September. Weekly downloads remained relatively stable, with a slight increase towards the end of the quarter, peaking at 24K. Active users saw a gradual increase, going from 58K to around 66K.
Clash of Clans, another hit from Supercell, showed a significant revenue peak of $167K in early August. Downloads varied but saw a notable rise to 27K at the start of August. Active users increased steadily, reaching 1.22M by the end of September.
Akinator by Elokence had modest weekly revenue, with a slight peak of $124 in the final week of September. Downloads showed a declining trend, from 20K in late June to about 12K in late September. Active users also decreased, from 69K to around 51K.
Genshin Impact from COGNOSPHERE PTE. LTD. saw a substantial revenue spike to $197K in mid-July. Downloads fluctuated, peaking at 23K in the last week of September. Active users showed a strong upward trend, ending the quarter at 191K.
These insights highlight the dynamic performance of high fantasy games in Latin America. For more detailed analysis, visit Sensor Tower.